The UJI effectively tests molecules capable of improving immunity or reducing inflammation of the tumour ecosyst (IMAGE)
Caption
Photo (from left to right): Alberto Pla, Raquel Gil, Celia Martín, Amelia Bou, Eva Falomir and Pedro Miguel Carda.
A team from the Universitat Jaume I in Castelló, led by researcher Eva Falomir Ventura, coordinator of the Chemistry for Medicine (JMC) group, has achieved promising results in testing molecules previously designed and synthesised by the same group. These molecules have the potential to block cancer cell growth by altering key microenvironment properties, such as immunity, inflammation, and the formation of new blood vessels.
In the different studies they are carrying out in the project ‘Development of new multi-target anti-cancer agents with a potential disruptive effect on the tumour microenvironment’, funded by the State Research Agency of the 2021-2023 State Plan for Scientific, Technical and Innovation Research, which ends in September 2025, the research team has synthesised and biologically evaluated more than a hundred small organic molecules of the aryltriazole and tetrazole types, of the styrene and styrylurea or styrylcarbamate derivatives types.
Credit
Universitat Jaume I of Castellón
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. Adaptations must be shared under the same terms.
License
CC BY-NC-SA